Company profile for BriSTAR Immunotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BriSTAR Immunotech is a clinical-stage biotechnology company focused on developing innovative engineered T-cell immunotherapies for cancer and viral infections. Founded in 2018, the company leverages its proprietary STAR-T and enTCR-T platforms to create next-generation therapies with enhanced tumor targeting, sensitivity, and efficacy. With strong scientific roots and advanced R&D capabilities, BriSTAR is committed to address...
BriSTAR Immunotech is a clinical-stage biotechnology company focused on developing innovative engineered T-cell immunotherapies for cancer and viral infections. Founded in 2018, the company leverages its proprietary STAR-T and enTCR-T platforms to create next-generation therapies with enhanced tumor targeting, sensitivity, and efficacy. With strong scientific roots and advanced R&D capabilities, BriSTAR is committed to addressing unmet medical needs and advancing precision cell therapies globally.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Beijing
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Arvo

Arvo

Not Confirmed

envelop Contact Supplier

Arvo

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty